N/A N=57 Randomized Treatment

Trial Evaluating Postop Pain and Muscle Strength Among Regional Anesthesia Techniques for Ambulatory ACL Reconstruction

Rupture of Anterior Cruciate Ligament · Tear of Anterior Cruciate Ligament

Bottom Line

View on ClinicalTrials.gov: NCT02584452 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2019

Primary outcome: Primary: Subjective Postoperative Pain Scores After Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to Preoperative Femoral Nerve Block Plus Postop Saphenous Nerve Block at 48 Hours After Discharge From PACU. — 1; 1; 2; 0 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Mepivacaine (Drug); adductor canal continuous nerve catheter (Procedure); Normal Saline as bolus followed by bupivacaine (Drug); adductor canal nerve block (Procedure); ropivacaine and dexamethasone (Drug); Propofol (Drug); Fentanyl (Drug)
Age: Pediatric, Adult, Older Adult · 14+ yrs
Sex: All
Sponsor: Vanderbilt University Medical Center
Primary completion: Mar 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Subjective Postoperative Pain Scores After Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to Preoperative Femoral Nerve Block Plus Postop Saphenous Nerve Block at 48 Hours After Discharge From PACU.	1; 1; 2; 0; 6; 3	—
PRIMARY Quadriceps Strength of on POD 1 of Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block at 48 Hours After Discharge From PACU	1; 2; 3; 7; 9; 4	—
SECONDARY Subjective Pain Scores on POD 1 of Patients Receiving (1) Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to (2) Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block	1; 0; 2; 1; 3; 1	—
SECONDARY Total Postop Opioid Consumption of Patients Receiving (1) Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to (2) Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block.	1; 0; 1; 0; 1; 0	—
SECONDARY Quadriceps Strength on POD Week 6- Pts Receiving (1) Long-acting Single Bolus Adductor Canal Nerve Block Comparied to (2) Continuous Adductor Canal Nerve Catheter.	1; 1; 15; 9; 15; 10	—
SECONDARY Physical Therapy Participation With a Subjective Assessment of Participant Ability to Participate in PT (Full, Partial, None)	27; 15; 4; 4; 0; 1	—
SECONDARY Subjective Postoperative Pain Score at Post Operative Week 6 of Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block	8; 9; 5; 1; 10; 1	—
SECONDARY Evaluation of Ambulation at Post Operative Week 6 Assessing Independently vs Assistance, With or Without Pain	6; 6; 18; 9; 3; 2	—
SECONDARY Postoperative Nausea and Vomiting	28; 17; 4; 4	—
SECONDARY Subjective Assessment of Experience With Analgesia	0; 2; 13; 7; 18; 11	—
SECONDARY Subjective Pain Scores on POD 3 of Patients Receiving (1) Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to (2) Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block	2; 2; 3; 1; 8; 2	—
SECONDARY Total Postop Opioid Consumption of Patients Receiving (1) Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to (2) Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block.	1; 0; 1; 0; 1; 0	—

Summary

Despite the apparent multifaceted benefit in differentiating blockade sites and duration of nerve blockade, the efficacy of continuous adductor canal blockade utilized specifically in ACL reconstruction has not been extensively studied. This study will test the hypothesis that the use of the adductor canal continuous nerve catheter will result in lower subjective pain scores on postoperative day 2 and improved quadriceps strength on postoperative day 1.

Eligibility Criteria

Inclusion Criteria

Age 14 and older
Patients who are scheduled to undergo an ACL reconstruction with patella or allograft
Patient does not have a contraindication to receiving regional anesthesia

Exclusion Criteria

Allergy to local anesthetics, dexamethasone, or adhesive tape
Patients undergoing hamstring graft for ACL
Preexisting infection at site of needle insertion
Immunocompromised patients
Preexisting sensory or motor deficit in operative extremity
Patient on chronic opioid treatment.
Patient having a revision of previous ACL reconstruction.
Pregnancy and lactating women

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02584452). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.